This time on LE 101, Veera discusses another primary hallmark of aging, epigenetic alterations, which affect the switches that turn genes on and off – and may be surprisingly easy to reverse.
LifeXtenShow – Epigenetic Alterations
Related Articles
October 23, 2020
In this panel discussion from Ending Age-Related Diseases 2020, Vadim Gladyshev of Harvard Medical School chairs a panel with Steve Horvath of UCLA, Kristen Fortney of BioAge Labs, Stanislav Skakun of Biodata, and Peter Fedichev […]
Posted in: News
October 22, 2020
A new analysis has revealed a core set of genes involved in aging in both humans and mice. Together with a broader set of age-related genes assembled […]
Posted in: News
October 21, 2020
The latest research published in the Journal of Tissue Engineering and Regenerative Medicine has reprogrammed pig fibroblast cells into neural progenitor cells.
Posted in: News
October 20, 2020
For this week’s episode of Lifespan News, Brent Nally presents an update on the state of today’s elderly, a new atlas of dental cells, a grant […]
Posted in: LifeXtenShow, News
Tags: Lifespan News
October 20, 2020
An international collective of scientists has discovered a new cellular process: telomere transfer from antigen-presenting cells to T cells that boosts the latter’s lifespan and proliferative potential [1]. […]
Posted in: News
October 19, 2020
Researchers have successfully used the CRISPR/Cas9 gene editing tool to destroy Ewing’s sarcoma and chronic myeloid leukemia tumor cells by targeting the fusion genes responsible for […]
October 16, 2020
In his presentation at Ending Age-Related Diseases 2020, LEAF board member Javier Noris discussed the Longevity Impact Fund, the reasons why biotechnology funding has been lacking, the "valley of death" that must be crossed in order to fully fund early-stage research through the clinical trial process, and new ways in which venture capital can fund...
Posted in: News
October 16, 2020
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new senolytic drugs. The companies have […]
Posted in: News
Write a comment: